Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The medical-industrial complex and conflict of interest in pain education.

Schatman ME.

Pain Med. 2011 Dec;12(12):1710-2. doi: 10.1111/j.1526-4637.2011.01284.x. No abstract available.

PMID:
22168303
2.

The medical-industrial complex, professional medical associations, and continuing medical education.

Schofferman J.

Pain Med. 2011 Dec;12(12):1713-9. doi: 10.1111/j.1526-4637.2011.01282.x. Epub 2011 Dec 6.

PMID:
22145759
3.

Commercial support for continuing medical education.

Mamdani MB, Mamdani B.

Issues Med Ethics. 1997 Apr-Jun;5(2):43-5. No abstract available.

PMID:
16267900
4.

Continuing medical education, physicians, and Pavlov: can we change what happens when industry rings the bell?

Lichter PR.

Arch Ophthalmol. 2008 Nov;126(11):1593-7. doi: 10.1001/archopht.126.11.1593. No abstract available.

PMID:
19001230
5.

[Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education].

Miyata Y.

Seishin Shinkeigaku Zasshi. 2010;112(11):1136-45. Review. Japanese.

PMID:
21226250
6.

Conflicts of interest.

Ripps RA.

Conn Med. 2009 Jan;73(1):37-8. No abstract available.

PMID:
19248573
7.

American academy of pain medicine ethics council statement on conflicts of interest: interaction between physicians and industry in pain medicine.

Dubois MY; American Academy of Pain Medicine Ethics Council.

Pain Med. 2010 Feb;11(2):257-62. doi: 10.1111/j.1526-4637.2009.00739.x. Epub 2009 Nov 17.

PMID:
19930112
8.

[The medical-industrial complex: an ethical challenge].

Engelhardt K.

Dtsch Med Wochenschr. 2005 Jul 29;130(30):1778-80. German. No abstract available.

PMID:
16049885
9.

Continuing medical education: ethical collaboration between sponsor and industry.

Wilson FS.

Clin Orthop Relat Res. 2003 Jul;(412):33-7. Review.

PMID:
12838049
10.

[Physicians and the drug industry. "To be like that, you'd better be married."].

Peiró S.

Rev Calid Asist. 2009 Apr;24(2):47-50. doi: 10.1016/S1134-282X(09)70652-9. Spanish. No abstract available.

PMID:
19426926
11.

Continuing medical education programs being placed under closer scrutiny.

Wilson B.

CMAJ. 2010 Oct 5;182(14):E683-4. doi: 10.1503/cmaj.109-3318. Epub 2010 Sep 7. No abstract available.

12.

CME, physicians, and Pavlov: can we change what happens when industry rings the bell?

Lichter PR.

Trans Am Ophthalmol Soc. 2008;106:39-43; discussion 44-5.

13.

Must "no see" always mean a "no know"?

Gamble GL.

PM R. 2009 Jan;1(1):87-8. doi: 10.1016/j.pmrj.2008.11.004. No abstract available.

PMID:
19627879
14.

Pharma PR or medical education?

Rentmeester CA.

Hastings Cent Rep. 2005 Mar-Apr;35(2):6. No abstract available.

PMID:
15957306
15.

US Senate committee investigates conflicts of interest in industry funded medical education.

Tanne JH.

BMJ. 2009 Aug 4;339:b3139. doi: 10.1136/bmj.b3139. No abstract available.

PMID:
19654162
16.

Current guidelines regarding industry-sponsored continuing medical education.

DelSignore JL.

Clin Orthop Relat Res. 2003 Jul;(412):21-7. Review.

PMID:
12838047
17.

Rebuttal: Is CME a drug-promotion tool?: NO.

Marlow B.

Can Fam Physician. 2007 Nov;53(11):1877, 1878-9. English, French. No abstract available.

18.

Industry funding for continuing medical education: is it ethical?

Heaphy DP, Marrow VB.

Arch Ophthalmol. 2004 May;122(5):771-3. No abstract available.

PMID:
15136327
19.

Continuing medical education and pharmaceutical industry.

Vakani FS, Jafri W, Amin A, Sheerani M.

J Coll Physicians Surg Pak. 2011 Jun;21(6):360-1. doi: 07.2011/JCPSP.360361.

PMID:
21711993
20.

Ethical concerns in industry support of continuing medical education: the con side.

Packer S, Parke DW 2nd.

Arch Ophthalmol. 2004 May;122(5):773-6. No abstract available.

PMID:
15136328

Supplemental Content

Support Center